交易激励
癌变
癌症研究
Wnt信号通路
肿瘤进展
转录因子
连环素
癌症
环状RNA
生物
癌细胞
下调和上调
基因
信号转导
细胞生物学
遗传学
作者
Feng Yang,Erhu Fang,Ming Hong,Yajun Chen,Huanhuan Li,Dan Li,Huajie Song,Jianqun Wang,Ming Hong,Wenjing Xiao,Xiaojing Wang,Kai Huang,Liduan Zheng,Qiangsong Tong
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2019-02-01
卷期号:79 (3): 557-571
被引量:129
标识
DOI:10.1158/0008-5472.can-18-1559
摘要
Circular RNAs (circRNA), a subclass of noncoding RNA characterized by covalently closed continuous loops, play emerging roles in tumorigenesis and aggressiveness. However, the functions and underlying mechanisms of circRNA in regulating Wnt/β-catenin signaling and cancer progression remain elusive. Here, we screen cis-acting circRNA generated by β-catenin (CTNNB1)/transcription factor 7-like 2 genes and identify one intronic circRNA derived from CTNNB1 (circ-CTNNB1) as a novel driver of cancer progression. Circ-CTNNB1 was predominantly expressed in the nucleus, upregulated in cancer tissues and cell lines, and associated with unfavorable outcomes in patients with cancer. Circ-CTNNB1 promoted β-catenin activation, growth, invasion, and metastasis in cancer cells. Circ-CTNNB1 bound DEAD-box polypeptide 3 (DDX3) to facilitate its physical interaction with transcription factor Yin Yang 1 (YY1), resulting in the transactivation of YY1 and transcriptional alteration of downstream genes associated with β-catenin activation and cancer progression. Preclinically, administration of lentivirus-mediated short hairpin RNA targeting circ-CTNNB1 or a cell-penetrating inhibitory peptide blocking the circ-CTNNB1-DDX3 interaction inhibited downstream gene expression, tumorigenesis, and aggressiveness in cancer cells. Taken together, these results demonstrate cis-acting circ-CTNNB1 as a mediator of β-catenin signaling and cancer progression through DDX3-mediated transactivation of YY1. SIGNIFICANCE: These findings reveal the oncogenic functions of a cis-acting circular RNA in β-catenin activation and cancer progression, with potential value as a therapeutic target for human cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI